Mendelian is helping doctors diagnose rare genetic diseases faster.
Mendelian has raised €2.2M across 2 funding rounds from 2 investors, most recently a Grant round in Mar 2023. Based in London, UK; founded 2015; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2023-03-03 | Grant | €1.6M | The Artificial Intelligence in Health and Care Awards | View deal → |
| 2019-01-01 | Other | €570k | Innovate UK | View deal → |
